S. Lazareno et al., SUBTYPE-SELECTIVE POSITIVE COOPERATIVE INTERACTIONS BETWEEN BRUCINE ANALOGS AND ACETYLCHOLINE AT MUSCARINIC RECEPTORS - RADIOLIGAND BINDING-STUDIES, Molecular pharmacology, 53(3), 1998, pp. 573-589
We studied the interactions of strychnine, brucine, and three of the N
-substituted analogues of brucine with [H-3]N-methylscopolamine (NMS)
and unlabeled acetylcholine at m1-m5 muscarinic receptors using equili
brium and nonequilibrium radioligand binding studies. The results were
consistent with a ternary allosteric model in which both the primary
and allosteric ligands bind simultaneously to the receptor and modify
the affinities of each other. The compounds had K-d values in the subm
illimolar range, inhibited [H-3]NMS dissociation, and showed various p
atterns of positive, neutral, and negative cooperativity with [H-3]NMS
and acetylcholine, but there was no predictive relationship between t
he effects. Acetylcholine affinity was increased similar to 2-fold by
brucine at m1 receptors, similar to 3-fold by N-chloromethyl brucine a
t m3 receptors, and similar to 1.5-fold by brucine-N-oxide at m4 recep
tors. The existence of neutral cooperativity, in which the compound bo
und to the receptor but did not modify the affinity of acetylcholine,
provides the opportunity for a novel form of drug selectivity that we
refer to as absolute subtype selectivity: an agent showing positive or
negative cooperativity with the endogenous ligand at one receptor sub
type and neutral cooperativity at the other subtypes would exert funct
ional effects at only the one subtype, regardless of the concentration
of agent or its affinities for the subtypes. Our results demonstrate
the potential for developing allosteric enhancers of acetylcholine aff
inity at individual subtypes of muscarinic receptor and suggest that m
inor modification of a compound showing positive, neutral, or low nega
tive cooperativity with acetylcholine may yield compounds with various
patterns of cooperativity across the receptor subtypes.